From this we could postulate that CCL17, CXCL1 and CCL2 act early and in a similar way to indirectly help tumour growth, possibly by upregulating CXCL10 production and myeloid cell expansion, which act more directly on tumour growth. The gene discussed is CCL2; the disease is neoplasm.